Robbins Umeda LLP Announces an Investigation of Crexus Investment Corporation
Robbins Umeda LLP, a shareholder rights litigation firm, has commenced an investigation into possible breaches of fiduciary duty and other violations of the law by certain officers and directors at Crexus Investment Corporation (NYSE: CXS).
Robbins Umeda LLP’s investigation focuses on whether officials at Crexus breached their fiduciary duties to shareholders, engaged in unjust enrichment, and wasted corporate assets to the detriment of the company and investors. In particular, the firm is investigating allegations that Annaly Capital Management, Inc., which operates and controls Crexus pursuant to a management agreement, caused Crexus to engage in the acquisition of high-risk assets financed through a $575 million stock offering that has significantly diluted the value of the company’s shares.
Additionally, the firm is examining allegations that officials at Crexus rejected an unsolicited merger proposal from Starwood Property Trust at $14 per share in favor of the dilutive stock offering which netted the company only $10.86 per share. After the offering, which increased the number of Crexus shares by 300%, shares of Crexus have continued to decrease in value. After trading as high as $12.81 on March 18, 2011, the company’s stock closed on September 13, 2011 at just $8.43 per share.
One option available to investors of Crexus is to file a derivative action to hold those that damaged Crexus accountable. Remedies commonly sought in derivative actions include corporate governance reforms designed to prevent future misconduct, removal of officers or directors whose misconduct injured the corporation, and monetary payments in the form of damages and/or disgorgement of ill-gotten gains.
If you own shares in Crexus and would like more information about your shareholder rights, please complete the form below and we will contact you directly. We also welcome you to call us at 800-350-6003.